Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • timread
    Member
    • Oct 2008
    • 14

    #1

    Hi y'all (greetings from Atlanta)

    A shoutout to the SEQanswers community from the south! My name is Tim Read, a newly minted Associate Professor in Infectious Diseases & Human Genetics at Emory University. I'm going to be running a new Genomics Core at Emory, based initially on the 454 GS-FLX and Illumina platforms, and continuing on my research on comparative bacterial pathogen genomics (previously I was an researcher at TIGR and then the Naval Medical Research Center in Rockville, Maryland).

    I'm on the lookout to recruit a couple of positions initially and will post the official descriptions shortly. These are: a lab tech/ lab manager experienced in running nextgen instruments, and a Bioinformatics analyst with experience in genome data analysis. Send me an email if you are interested or come and find me at AGBT.

    all the best
    Tim

    (BTW - I'm British so I don't actually talk Southern on a full time basis )
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    Hey Tim,

    Welcome, good to have you! I'm trying to hear "ya'all" in a British accent.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    67 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    47 views
    0 reactions
    Last Post SEQadmin2  
    Working...